FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3100994723> ?p ?o ?g. }

• W3100994723 endingPage "e001427" @default.
• W3100994723 startingPage "e001427" @default.
• W3100994723 abstract "Background Adverse events (AEs) of special interest that arise during treatment with immune checkpoint inhibitors, including immune-related AEs (irAEs), have been reported to be associated with improved clinical outcomes. We analyzed patients treated with avelumab from the JAVELIN Solid Tumor and Merkel 200 trials, examining the association between AEs and efficacy while adjusting for confounding factors such as treatment duration and event order. Methods We analyzed efficacy and safety data from 1783 patients treated with the programmed death ligand 1 inhibitor avelumab who were enrolled in expansion cohorts of the JAVELIN Solid Tumor and Merkel 200 trials. To analyze the association between irAEs and efficacy with regard to survival, we used a time-dependent Cox model with time-varying indicators for irAEs, as well as multistate models that accounted for competing risks and time inhomogeneity. Results 295 patients (16.5%) experienced irAEs and 454 patients (25.5%) experienced infusion-related reactions. There was a reduced risk of death in patients who experienced irAEs compared with those who did not (HR 0.71, 95% CI 0.59 to 0.85) using the time-dependent Cox model. The multistate model did not suggest that the occurrence of irAEs could predict response; however, it predicted a higher chance of irAEs occurring after a response. No association was observed between response and infusion-related reactions. Conclusions Patients who experience irAEs showed improved survival. Although irAEs are not predictors for response to immune checkpoint inhibitors, increased vigilance for irAEs is needed after treatment with avelumab. Trial registration numbers NCT01772004 and NCT02155647 ." @default.
• W3100994723 created "2020-11-23" @default.
• W3100994723 creator A5005718112 @default.
• W3100994723 creator A5008456468 @default.
• W3100994723 creator A5015358832 @default.
• W3100994723 creator A5016238643 @default.
• W3100994723 creator A5017411957 @default.
• W3100994723 creator A5039083730 @default.
• W3100994723 creator A5054628640 @default.
• W3100994723 creator A5070669850 @default.
• W3100994723 creator A5083000419 @default.
• W3100994723 creator A5089731384 @default.
• W3100994723 creator A5091542924 @default.
• W3100994723 date "2020-11-01" @default.
• W3100994723 modified "2023-10-16" @default.
• W3100994723 title "Efficacy and immune-related adverse event associations in avelumab-treated patients" @default.
• W3100994723 cites W1820495241 @default.
• W3100994723 cites W1955438485 @default.
• W3100994723 cites W1970810241 @default.
• W3100994723 cites W1985540222 @default.
• W3100994723 cites W1988089698 @default.
• W3100994723 cites W2024703759 @default.
• W3100994723 cites W2049484790 @default.
• W3100994723 cites W2105057287 @default.
• W3100994723 cites W2132916434 @default.
• W3100994723 cites W2153942285 @default.
• W3100994723 cites W2179179825 @default.
• W3100994723 cites W2265285917 @default.
• W3100994723 cites W2296047035 @default.
• W3100994723 cites W2473218705 @default.
• W3100994723 cites W2513176323 @default.
• W3100994723 cites W2597811717 @default.
• W3100994723 cites W2664619167 @default.
• W3100994723 cites W2754877046 @default.
• W3100994723 cites W2759963646 @default.
• W3100994723 cites W2762786216 @default.
• W3100994723 cites W2770404972 @default.
• W3100994723 cites W2783137027 @default.
• W3100994723 cites W2789502254 @default.
• W3100994723 cites W2793286287 @default.
• W3100994723 cites W2809615201 @default.
• W3100994723 cites W2891633409 @default.
• W3100994723 cites W2891978472 @default.
• W3100994723 cites W2893221436 @default.
• W3100994723 cites W2896274372 @default.
• W3100994723 cites W2897812540 @default.
• W3100994723 cites W2898251416 @default.
• W3100994723 cites W2903486314 @default.
• W3100994723 cites W2905314444 @default.
• W3100994723 cites W2912725678 @default.
• W3100994723 cites W2914940499 @default.
• W3100994723 cites W2918511688 @default.
• W3100994723 cites W2924070172 @default.
• W3100994723 cites W2939940798 @default.
• W3100994723 cites W2942467666 @default.
• W3100994723 cites W2945674342 @default.
• W3100994723 cites W2981366973 @default.
• W3100994723 cites W2988124258 @default.
• W3100994723 cites W2997720498 @default.
• W3100994723 cites W3004284786 @default.
• W3100994723 cites W4210394199 @default.
• W3100994723 cites W619721244 @default.
• W3100994723 doi "https://doi.org/10.1136/jitc-2020-001427" @default.
• W3100994723 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7682456" @default.
• W3100994723 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33219092" @default.
• W3100994723 hasPublicationYear "2020" @default.
• W3100994723 type Work @default.
• W3100994723 sameAs 3100994723 @default.
• W3100994723 citedByCount "11" @default.
• W3100994723 countsByYear W31009947232021 @default.
• W3100994723 countsByYear W31009947232022 @default.
• W3100994723 countsByYear W31009947232023 @default.
• W3100994723 crossrefType "journal-article" @default.
• W3100994723 hasAuthorship W3100994723A5005718112 @default.
• W3100994723 hasAuthorship W3100994723A5008456468 @default.
• W3100994723 hasAuthorship W3100994723A5015358832 @default.
• W3100994723 hasAuthorship W3100994723A5016238643 @default.
• W3100994723 hasAuthorship W3100994723A5017411957 @default.
• W3100994723 hasAuthorship W3100994723A5039083730 @default.
• W3100994723 hasAuthorship W3100994723A5054628640 @default.
• W3100994723 hasAuthorship W3100994723A5070669850 @default.
• W3100994723 hasAuthorship W3100994723A5083000419 @default.
• W3100994723 hasAuthorship W3100994723A5089731384 @default.
• W3100994723 hasAuthorship W3100994723A5091542924 @default.
• W3100994723 hasBestOaLocation W31009947231 @default.
• W3100994723 hasConcept C121608353 @default.
• W3100994723 hasConcept C126322002 @default.
• W3100994723 hasConcept C143998085 @default.
• W3100994723 hasConcept C197934379 @default.
• W3100994723 hasConcept C2777381376 @default.
• W3100994723 hasConcept C2777701055 @default.
• W3100994723 hasConcept C2780057760 @default.
• W3100994723 hasConcept C50382708 @default.
• W3100994723 hasConcept C535046627 @default.
• W3100994723 hasConcept C71924100 @default.
• W3100994723 hasConcept C77350462 @default.
• W3100994723 hasConceptScore W3100994723C121608353 @default.
• W3100994723 hasConceptScore W3100994723C126322002 @default.

• next